Szalóki, G., Krasznai, Z. T., Tóth, Á., Vízkeleti, L., Szöllősi, A. G., Trencsényi, G., . . . Goda, K. (2014). The Strong In Vivo Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity. Public Library of Science.
Citação norma ChicagoSzalóki, Gábor, et al. The Strong In Vivo Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity. Public Library of Science, 2014.
ציטוט MLASzalóki, Gábor, et al. The Strong In Vivo Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity. Public Library of Science, 2014.